Evidence mapPaperPMID 39199307Full record

ReviewBiomolecules2024

Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis.

Shangze Guo, Yinghao Tong, Ting Li, Kexin Yang, Wei Gao, Fujun Peng, Xiangyu Zou

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shangze GuoSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
Yinghao TongSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
Ting LiSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
Kexin YangSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
Wei GaoSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
Fujun PengSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.
Xiangyu ZouSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China.

Funding

the National Natural Science Foundation of China 81900618the Program of Scientific and Technological Development of Weifang 2023GX026the Tai-Shan Scholar Program from Shandong Province tsqn202103116
6 · The paper itself

Abstract

The endoplasmic reticulum (ER) is indispensable for maintaining normal life activities. Dysregulation of the ER function results in the accumulation of harmful proteins and lipids and the disruption of intracellular signaling pathways, leading to cellular dysfunction and eventual death. Protein misfolding within the ER disrupts its delicate balance, resulting in the accumulation of misfolded or unfolded proteins, a condition known as endoplasmic reticulum stress (ERS). Renal fibrosis, characterized by the aberrant proliferation of fibrotic tissue in the renal interstitium, stands as a grave consequence of numerous kidney disorders, precipitating a gradual decline in renal function. Renal fibrosis is a serious complication of many kidney conditions and is characterized by the overgrowth of fibrotic tissue in the glomerular and tubular interstitium, leading to the progressive failure of renal function. Studies have shown that, during the onset and progression of kidney disease, ERS causes various problems in the kidneys, a process that can lead to kidney fibrosis. This article elucidates the underlying intracellular signaling pathways modulated by ERS, delineating its role in triggering diverse forms of cell death. Additionally, it comprehensively explores a spectrum of potential pharmacological agents and molecular interventions aimed at mitigating ERS, thereby charting novel research avenues and therapeutic advancements in the management of renal fibrosis.

Indexed as

Cell DeathEndoplasmic Reticulum StressFibrosisKidney DiseasesAnimalsEndoplasmic ReticulumHumansKidneySignal TransductionUnfolded Protein Responsecell deathendoplasmic reticulum stressrenal fibrosis

Identifiers

PMID39199307
PMCPMC11352060

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.